This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Wednesday's Small-Cap Winners & Losers

Florida-based Nabi Biopharmaceuticals (NABI) was also rising after a phase IIb trial of NicVax -- its proposed treatment for nicotine addiction -- achieved its primary endpoint. Shares surged 12.7% to $5.79. Elsewhere in the health sector, California's Pain Therapeutics (PTIE) gained 13.1% to $8.65 after it posted a 28-cent per-share profit in the first quarter, which powered past analysts' downside expectations.

Among small-cap health laggards, however, was CollaGenex Pharmaceuticals (CGPI), which said a patient in midphase testing for its proposed acne treatment, incyclinide, sustained "apparent significant photo-toxicity" -- a severe reaction to sunlight and "a known side effect of tetracyclines," of which incyclinide is a modified form. The Newton, Pa., drugmaker is investigating the incident and, in the interim, has halted further enrollment in the study. Shares were losing more than 18% at $11.45.

Meanwhile, Canada's Neurochem (NRMX) slid 16% to $9.74 on word it privately sold $80 million in convertible bonds, and fellow drugmaker Santarus (SNTS), of San Diego, was off 12.3% at $6.95 after losing 3 cents more per share in the first quarter than Wall Street had predicted.

Returning to the tech sector, real-estate Web site Move (MOVE) broke even in the first quarter, missing analysts' projections by 2 cents despite gaining 2 cents on last year. The California-based company recently plunged 10% to $4.23. And Florida-based Forward (FORD), which makes accessories for handheld electronics, swung to a small loss from penny-a-share profits a year ago. Shares sank 15% at $3.40.

The Russell 2000 Index lately jumped 12.09 points, or 1.5%, to 828.34. The S&P Small-Cap 600 Index gained 6.79, or 1.6%, at 429.57.

2 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,577.56 +220.69 1.27%
S&P 500 2,038.38 +25.49 1.27%
NASDAQ 4,709.6490 +65.3370 1.41%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs